Video
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone
Apr 3, 2018
Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone
May 16, 2017
Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone
Feb 25, 2015